ClariTrial | Search Clinical Trials

Explore/diabetes obesity metabolic disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

736 results for “diabetes obesity metabolic disease” · Recruiting

Page 1 of 50

Recruiting

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

N/AObesity Type 2 Diabetes MellitusObesity (Disorder)

GLP-1 Therapy

University of South Carolina50 participants2 sites · United StatesCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

N/AOverweight or Obesity

NDPP-NextGen

Wake Forest University Health Sciences403 participants1 site · United StatesCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism

N/AObesityDiabetes Mellitus, Type 2

surgery

German Diabetes Center450 participants1 site · GermanyCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

N/ADiabetes Mellitus, Type 2InsulinFructosamine

AvocadoOther Fruit(s)

Pennington Biomedical Research Center48 participants1 site · United StatesCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids

N/AInsulin Resistance

IntralipidPalm Oil EmulsionSaline

Mayo Clinic60 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?

Phase 4Kidney Transplant; ComplicationsKidney Transplant FailureRenal Failure

Dapagliflozin 10mg TabPlacebo

Oslo University Hospital330 participants1 site · NorwayCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

Phase 3Obesity and Overweight

MET097Placebo

Metsera, a wholly owned subsidiary of Pfizer3,500 participants196 sites · United States, Argentina, BulgariaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

N/AObesity and Type 2 DiabetesMetabolic DiseasesHigh-intensity Interval Training

High-intensity interval trainingTime-restricted eating

Syracuse University40 participants1 site · United StatesCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Phase 2Obesity

Retatrutide (LY3437943)PlaceboStandardized diet and physical activity counseling throughout the study.

Hudson Biotech300 participants1 site · ChinaCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

N/ADiabetes Mellitus, Type 2Overweight and ObesityNon-Alcoholic Fatty Liver Disease

Dietary macronutrient composition

Hvidovre University Hospital14 participants1 site · DenmarkCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

N/AObesity

Weight loss

University of Pittsburgh205 participants3 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

N/AObesity

Yonsei University650 participants1 site · South KoreaCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

NAFLD Primary Care

N/ANon-Alcoholic Fatty Liver DiseaseCardiovascular DiseasesType2 Diabetes

FibroScan

Maastricht University1,470 participants1 site · NetherlandsCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD

N/AMetabolic Dysfunction-associated Steatotic Liver Disease

Fundacion de Investigacion Science and Education100 participants1 site · Puerto RicoCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction

N/ADiabetes Mellitus Type 2 in Obese

Low carb diet

Region Stockholm286 participants1 site · SwedenCompletes Feb 2027

Compare CT.gov Full analysis →

1–15 of 736

Explore/diabetes obesity metabolic disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

736 results for “diabetes obesity metabolic disease” · Recruiting

Page 1 of 50

Recruiting

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

N/AObesity Type 2 Diabetes MellitusObesity (Disorder)

GLP-1 Therapy

University of South Carolina50 participants2 sites · United StatesCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

N/AOverweight or Obesity

NDPP-NextGen

Wake Forest University Health Sciences403 participants1 site · United StatesCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism

N/AObesityDiabetes Mellitus, Type 2

surgery

German Diabetes Center450 participants1 site · GermanyCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

N/ADiabetes Mellitus, Type 2InsulinFructosamine

AvocadoOther Fruit(s)

Pennington Biomedical Research Center48 participants1 site · United StatesCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids

N/AInsulin Resistance

IntralipidPalm Oil EmulsionSaline

Mayo Clinic60 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?

Phase 4Kidney Transplant; ComplicationsKidney Transplant FailureRenal Failure

Dapagliflozin 10mg TabPlacebo

Oslo University Hospital330 participants1 site · NorwayCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

Phase 3Obesity and Overweight

MET097Placebo

Metsera, a wholly owned subsidiary of Pfizer3,500 participants196 sites · United States, Argentina, BulgariaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

N/AObesity and Type 2 DiabetesMetabolic DiseasesHigh-intensity Interval Training

High-intensity interval trainingTime-restricted eating

Syracuse University40 participants1 site · United StatesCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Phase 2Obesity

Retatrutide (LY3437943)PlaceboStandardized diet and physical activity counseling throughout the study.

Hudson Biotech300 participants1 site · ChinaCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

N/ADiabetes Mellitus, Type 2Overweight and ObesityNon-Alcoholic Fatty Liver Disease

Dietary macronutrient composition

Hvidovre University Hospital14 participants1 site · DenmarkCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

N/AObesity

Weight loss

University of Pittsburgh205 participants3 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

N/AObesity

Yonsei University650 participants1 site · South KoreaCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

NAFLD Primary Care

N/ANon-Alcoholic Fatty Liver DiseaseCardiovascular DiseasesType2 Diabetes

FibroScan

Maastricht University1,470 participants1 site · NetherlandsCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD

N/AMetabolic Dysfunction-associated Steatotic Liver Disease

Fundacion de Investigacion Science and Education100 participants1 site · Puerto RicoCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction

N/ADiabetes Mellitus Type 2 in Obese

Low carb diet

Region Stockholm286 participants1 site · SwedenCompletes Feb 2027

Compare CT.gov Full analysis →

1–15 of 736